US › Healthcare

Owlet Inc (OWLT)

US · Healthcare · Medical Devices

$4.11-7.43%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$33.9M

Revenue YoY

+30.1%

Net profit

$-600,000

EPS

$-0.05

EPS estimate

$-0.08

Net margin

-1.8%

EPS came in at -0.05 against a street estimate of -0.08 — a beat of 37.5%.

Key statistics

Market cap

$135.3M

Forward P/E

0.0

P/B

6.06

Book value

$0.80

EPS (TTM)

$-0.55

52-week high

$16.94

52-week low

$4.19

50-day MA

$5.17

200-day MA

$7.17

Beta

1.91

Analyst view

Analysts rate Owlet Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $13.00.

Shareholding

Insiders

10.66%

Institutions

72.50%

Largest institutional holders

Fund	Stake
ECLIPSE VENTURES, LLC	26.50%
Granahan Investment Management Inc..	5.49%
Cannell Capital LLC	4.25%
Awm Investment Company Inc	4.22%
Vanguard Capital Management, LLC	2.76%
Ameriprise Financial Inc	1.76%
Jacobs Levy Equity Management, Inc.	1.14%
Harbor Capital Advisors Inc	1.14%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Owlet Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.